| Symbol: | NLRP6 |
| Also known as: | NALP6, PYPAF5, CIAS5 |
| UniProt: | [P59044](https://www.uniprot.org/uniprot/P59044) |
| Gene: | [NLRP6](/genes/nlrp6) |
| MW: | 100.9 kDa |
| Location: | Cytoplasm |
| PDB: | [3QF2](https://www.rcsb.org/structure/3QF2) |
NLRP6 (NACHT, LRR and PYD Domains-Containing Protein 6) is a member of the NLR (NOD-like receptor) family of pattern recognition receptors that forms an inflammasome complex in response to microbial and endogenous danger signals. While less studied than its family member NLRP3, NLRP6 plays critical roles in maintaining gut homeostasis, regulating the gut-brain axis, and modulating neuroinflammation[1].
NLRP6 has emerged as a key player in the bidirectional communication between the gut microbiome and the central nervous system, with implications for neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and multiple sclerosis[2][3].
NLRP6 is an 892-amino acid protein with the characteristic NLR domain structure:
PYD Domain (Pyrin Domain, residues 1-92):
NACHT Domain (residues 143-420):
LRR Domain (Leucine-Rich Repeats, residues 460-892):
Upon activation, NLRP6 oligomerizes and recruits:
This results in formation of the ASC speck and caspase-1 activation[5].
NLRP6 is critical for intestinal health:
Mucus Secretion: NLRP6 regulates goblet cell mucus granule exocytosis and maintains the mucus barrier[6].
Microbiome Composition: NLRP6 deficiency leads to dysbiosis characterized by:
Antimicrobial Peptides: NLRP6 regulates secretion of antimicrobial peptides including RegIIIγ and cryptdins.
Epithelial Repair: NLRP6 modulates intestinal stem cell proliferation and epithelial regeneration[7].
The NLRP6 inflammasome mediates:
IL-1β and IL-18 Maturation: Caspase-1 cleaves pro-IL-1β and pro-IL-18.
Pyroptosis: Caspase-1 activates gasdermin D, causing inflammatory cell death.
IL-18-Mediated Repair: IL-18 promotes tissue repair and antimicrobial responses.
NLRP6 has both pro- and anti-inflammatory roles:
Anti-inflammatory: Can suppress NF-κB and MAPK signaling in some contexts.
Pro-inflammatory: Promotes cytokine release and immune cell recruitment via inflammasome activation.
Microbiome Sensing: Detects microbial metabolites and maintains homeostasis[8].
NLRP6's primary relevance to neurodegeneration is through gut-brain communication:
Leaky Gut: NLRP6 deficiency causes intestinal barrier dysfunction, allowing bacterial products to enter circulation.
Systemic Inflammation: Dysbiosis in NLRP6 deficiency leads to systemic inflammation that can affect the brain.
Microbial Metabolites: Altered microbiome composition affects production of neuroactive metabolites:
NLRP6 implications in AD include:
Neuroinflammation: Gut dysbiosis can exacerbate neuroinflammation in AD.
Aβ Pathology: Systemic inflammation accelerates Aβ accumulation.
Microglial Activation: Peripheral inflammation primes microglia for enhanced responses.
Blood-Brain Barrier: NLRP6 deficiency may affect BBB integrity through systemic effects[10].
The gut-brain axis is particularly relevant in PD:
α-Synuclein: Gut inflammation may trigger α-synuclein aggregation that spreads to the brain.
Vagal Pathway: Inflammatory signals may propagate via the vagus nerve.
Constipation: GI symptoms often precede motor symptoms in PD, suggesting gut involvement.
NLRP6 Expression: NLRP6 is expressed in enteric neurons and may regulate gut motility[11].
NLRP6 plays complex roles in MS:
EAE Model: NLRP6 deficiency can worsen or improve EAE depending on context.
IL-18 Effects: IL-18 produced by NLRP6 inflammasome has both protective and detrimental effects.
Microbiome Effects: Gut dysbiosis from NLRP6 deficiency affects autoimmune responses.
T Cell Regulation: NLRP6 may regulate Th17 cell differentiation via microbiome effects[12].
NLRP6 in cerebral ischemia:
Inflammasome Activation: NLRP6 is upregulated in ischemic brain.
Neuroinflammation: NLRP6 deficiency can reduce inflammatory damage.
BBB Disruption: NLRP6 may contribute to BBB breakdown after stroke[13].
| Approach | Mechanism | Status |
|---|---|---|
| MCC950/CRID3 | Inhibits NLRP3; may affect NLRP6 | Preclinical |
| OLT1177 (Dapansutrile) | NLRP3 inhibitor; cross-reactivity? | Clinical trials |
| ASC inhibitors | Block inflammasome assembly | Preclinical |
Inflammasome Inhibition: Blocking NLRP6 inflammasome activation may reduce inflammation.
Microbiome Modulation: Probiotics or fecal transplant to correct dysbiosis in NLRP6 deficiency.
IL-18 Supplementation: May restore homeostasis in some contexts.
Barrier Enhancement: Therapies to strengthen gut and blood-brain barriers[14].
Dual Roles: NLRP6 has both protective and harmful effects depending on context.
Tissue Specificity: NLRP6 function differs between gut, brain, and other organs.
Redundancy: Other inflammasomes may compensate for NLRP6 inhibition.
Microbiome Complexity: Effects depend on individual microbiome composition[15].
| Interactor | Type | Function |
|---|---|---|
| ASC (PYCARD) | Adaptor | Inflammasome assembly |
| Caspase-1 | Enzyme | Cytokine maturation |
| Pro-IL-1β | Substrate | Pro-inflammatory cytokine |
| Pro-IL-18 | Substrate | Immunomodulatory cytokine |
| TAK1 | Kinase | NF-κB regulation |
| Microbiome | Ligand source | Activation/inhibition |
Grenier JM, Wang L, Chamaillard M, et al. [Functional screening of five PYPAF family members identifies PYPAF5 as a novel regulator of NF-kappaB and caspase-1](https://doi.org/10.1016/s0014-5793(02). FEBS Lett. 2002. ↩︎
Wlodarska M, Thaiss CA, Nowarski R, et al. NLRP6 inflammasome orchestrates the colonic host-microbial interface by regulating goblet cell mucus secretion. Cell. 2014. ↩︎
Levy M, Thaiss CA, Zeevi D, et al. Microbiota-Modulated Metabolites Shape the Intestinal Microenvironment by Regulating NLRP6 Inflammasome Signaling. Cell. 2015. ↩︎
Hu Z, Zhou Q, Chen W, et al. Structural and biochemical basis for induced self-propagation of NLRC4. Science. 2015. ↩︎
Elinav E, Strowig T, Kau AL, et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell. 2011. ↩︎
Birchenough GM, Nyström EE, Johansson ME, et al. A sentinel goblet cell guards the colonic crypt by triggering Nlrp6-dependent Muc2 secretion. Science. 2016. ↩︎
Radeski D, Cao S, Fung C, et al. NLRP6 modulates intestinal epithelial repair after injury. Gut. 2022. ↩︎
Anand PK, Malireddi RK, Lukens JR, et al. NLRP6 negatively regulates innate immunity and host defence against bacterial pathogens. Nature. 2012. ↩︎
Zhao Y, Jaber V, Lukiw WJ. Gastrointestinal Tract Microbiome-Derived Pro-Inflammatory Neurotoxins in Alzheimer's Disease. J Aging Sci. 2023. ↩︎
Shen S, Liao Q, Zhang T, et al. NLRP6 in Alzheimer's disease: A potential therapeutic target. Neurobiol Aging. 2024. ↩︎
Perez-Pardo P, Dodiya HB, Engen PA, et al. Gut-brain axis in Parkinson's disease: The role of gut inflammation and dysbiosis. NPJ Parkinsons Dis. 2018. ↩︎
Mamantopoulos M, Ronchi F, Van Hauwermeiren F, et al. Nlrp6- and Asc-Dependent Inflammasomes Do Not Shape the Commensal Gut Microbiota Composition. Immunity. 2017. ↩︎
Chen S, Sun B, Zheng N, et al. NLRP6 inflammasome deficiency aggravates acute cerebral ischemia/reperfusion injury. Neurochem Int. 2022. ↩︎
Henao-Mejia J, Elinav E, Jin C, et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature. 2012. ↩︎
Das S, Shapiro B, Vargas HA, et al. NLRP6 inhibits protective immunity to gut infection. Cell Rep. 2020. ↩︎